Novo Nordisk
NVO
#100
Rank
โ‚น17.204 T
Marketcap
โ‚น3,879
Share price
6.88%
Change (1 day)
-27.46%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.827 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.70 Billion. , an increase over its 2024 earnings that were of โ‚น1.858 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น1.975 T6.28%
2024 โ‚น1.858 T28.01%
2023 โ‚น1.451 T57.81%
2022 โ‚น919.87 B5.24%
2021 โ‚น874.11 B12.38%
2020 โ‚น777.80 B13.11%
2019 โ‚น687.66 B-3.45%
2018 โ‚น712.22 B1.88%
2017 โ‚น699.06 B4.3%
2016 โ‚น670.22 B10.32%
2015 โ‚น607.51 B7.47%
2014 โ‚น565.30 B3.4%
2013 โ‚น546.70 B19.09%
2012 โ‚น459.08 B15.58%
2011 โ‚น397.21 B16.58%
2010 โ‚น340.72 B25.66%
2009 โ‚น271.15 B10.68%
2008 โ‚น244.99 B55.82%
2007 โ‚น157.23 B7.02%
2006 โ‚น146.91 B19.05%
2005 โ‚น123.40 B10.55%
2004 โ‚น111.62 B
2002 โ‚น76.77 B-14.39%
2001 โ‚น89.67 B-52.82%
2000 โ‚น190.06 B250%
1999 โ‚น54.30 B31.21%
1998 โ‚น41.38 B34.31%
1997 โ‚น30.81 B11.46%
1996 โ‚น27.64 B9.03%
1995 โ‚น25.35 B-3.15%
1994 โ‚น26.17 B-0.67%
1993 โ‚น26.35 B45.38%
1992 โ‚น18.12 B-13.81%
1991 โ‚น21.03 B37.12%
1990 โ‚น15.33 B-0.79%
1989 โ‚น15.46 B26.2%
1988 โ‚น12.25 B24.97%
1987 โ‚น9.80 B-0.9%
1986 โ‚น9.89 B-7.78%
1985 โ‚น10.72 B24.87%
1984 โ‚น8.59 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น960.29 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.424 T 22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น725.42 B-63.27%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น878.88 B-55.50%๐Ÿ‡บ๐Ÿ‡ธ USA